Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of July 15, 2026, SNDX trades at $24.59 with a market cap of $2.03B and a P/E ratio of -7.23. SNDX moved +5.50% today. Year to date, SNDX is +14.85%; over the trailing twelve months it is +144.97%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $36.38. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SNDX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $24.59 |
| Market Cap | $2.03B |
| P/E Ratio | -7.23 |
| EPS | $-3.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.59 |
| 52-Week Low | $8.58 |
| Volume | 1.78M |
| Avg Volume | 0 |
| Revenue (TTM) | $172.35M |
| Net Income | $-285.42M |
| Gross Margin | 0.00% |
9 analysts cover SNDX: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.38.